share_log
Reuters ·  20:00
ProMIS Neurosciences Inc - Phase 1a Study Shows Favorable Safety Profile for Pmn310
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment